Zenotech Laboratories Ltd.
| BSE: 532039 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE486F01012 |
| BSE 00:00 | 13 Apr | 38.20 |
-0.45 (-1.16%) |
OPEN
37.00 |
HIGH
40.35 |
LOW
37.00 |
| NSE 05:30 | 01 Jan | Zenotech Laboratories Ltd |
| OPEN | 37.00 |
| PREVIOUS CLOSE | 38.65 |
| VOLUME | 7523 |
| 52-Week high | 47.90 |
| 52-Week low | 17.95 |
| P/E | |
| Mkt Cap.(Rs cr) | 233 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Zenotech Laboratories Ltd. (ZENOTECHLAB) - News Sector
-
Dr Reddy's stock sheds 4% as Sputnik V pricing, competition weigh
11.34 pm | 13 Apr 2021 | Business Standard
Access to the private market, international sales are other factors that will impact margins
-
Dr Reddy's to submit more data on Covid-19 vaccine Sputnik V by July
1.09 am | 13 Apr 2021 | Business Standard
Colour-coded doses will have two different antigens
-
Dr Reddys surges 5% as Sputnik V gets expert panel nod for emergency use
3.57 pm | 12 Apr 2021 | Business Standard
This is the third vaccine approved by India, after Covishield and Covaxin.
-
Anupam Rasayan rebounds 13% from day's low on repaying debt worth Rs 471 cr
3.02 pm | 12 Apr 2021 | Business Standard
The debt repayment will result in significant savings in the finance cost, it said
-
Solara Active Pharma extends gains, rallies 12% on merger with Aurore Life
12.12 pm | 12 Apr 2021 | Business Standard
Solara Active and Aurore Life Sciences' amalgamation would create one of the largest API players in the industry
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Pharma shares in demand; Cipla, Laurus Labs, Dr Lal Pathlabs hit new highs
11.02 am | 12 Apr 2021 | Business Standard
Analysts at Phillip Capital believe that it is not over for the Indian pharma - and that it is all set for a sectoral value upgrade
-
Nifty outlook and stock picks by Sameet Chavan: Buy Balrampur Chini, Pfizer
8.57 am | 12 Apr 2021 | Business Standard
The deciding factor in days to come has to be the financial space
-
Cyclical sectors are expected to drive March 2020 quarter earnings growth
8.31 am | 12 Apr 2021 | Business Standard
Bank results are especially eagerly awaited in this quarter. The Supreme Court has lifted its stay order, which means that banks can report NPAs reali...
-
Here is a Bull Spread Strategy on Glenmark Pharma by HDFC Securities
8.28 am | 9 Apr 2021 | Business Standard
The stock price has already given bullish breakout from the downward slopping trendline adjoining the highs of 08-Dec-2020 and 12-Jan-2021
-
Small-Cap index hits new high; analysts see more upside
1.14 am | 9 Apr 2021 | Business Standard
A large part of this rally is attributed to the economic recovery over the past few months, which analysts feel will directly benefit small and mid-si...
-
Small-Cap index hits new high; analysts see more upside
1.14 am | 9 Apr 2021 | Business Standard
A large part of this rally is attributed to the economic recovery over the past few months, which analysts feel will directly benefit small and mid-si...
-
This stock from Dolly Khanna's portfolio has rallied 121% so far in 2021
3.02 pm | 6 Apr 2021 | Business Standard
Dolly Khanna acquired 161,336 equity shares or 1.26 per cent stake in Neuland Lab during the quarter ended March 2021
-
Laurus Labs rallies 6%, hits record high on heavy volume
10.14 am | 6 Apr 2021 | Business Standard
The pharmaceutical company's stock surpassed its previous high of Rs 386, touched on January 25, 2021
Quick Links for Zenotech Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
